Search Within

Malin Lisa Hultcrantz

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (171)
  2. Journal Article (68)
  3. Research Letter (9)
  4. Guidelines (6)
  5. Review (3)
  6. Correspondence (2)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (260)
  2. Department of Medicine (260)
  3. Hematologic Malignancies, Division of (260)
  4. Myeloma (260)
  5. Sloan Kettering Institute Postdocs (260)
  6. Hematologic Malignancies Research (179)

More Groups

People
  1. Sham Mailankody (148)
  2. Neha Korde (145)
  3. Alexander Lesokhin (140)
  4. Hani Hassoun (135)
  5. Urvi Shah (125)
  6. Heather Landau (119)

More People

Years
  1. 2025 (8)
  2. 2024 (39)
  3. 2023 (51)
  4. 2022 (52)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (50)
  3. Journal of Clinical Oncology (17)
  4. Blood Cancer Journal (13)
  5. Haematologica (10)
  6. Blood Advances (6)

More Publications

Publishers
  1. American Society of Hematology (103)
  2. Elsevier Inc. (55)
  3. Nature Publishing Group (21)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (10)
  6. American Association for Cancer Research (6)

More Publishers

Results (260)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating the effect of evolving changes in serum biomarkers on the risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K. H.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A comparative analysis of infectious complications in patients with multiple myeloma treated with BCMA-targeted bispecific antibodies and CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Shekarkhand, T.; Costa, B. A.; Nemirovsky, D.; Derkach, A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D.; Landau, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Multiple myeloma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D.; Baljevic, M.; Baz, R.; Campagnaro, E.; Castillo, J. J.; Costello, C.; D'Angelo, C.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: Results from the population-based iStopMM study
    Journal Article

    Sigurbergsdóttir, A. Ý; Rögnvaldsson, S.; Thorsteinsdóttir, S.; Sverrisdóttir, I.; Sigurðardóttir, G. Á; Viðarsson, B.; Önundarson, P. T.; Agnarsson, B. A.; Sigurðardóttir, M.; Þorsteinsdóttir, I.; more...
    Haematologica (2023)

    Fulltext@MSK | Save